Because of the potential adverse effects leptin, including its tendency to stimulate angiogenesis (Skrypnik et al., 2021) and carcinogenesis (Lin and Hsiao, 2021), and to aggravate autoimmune disease (Procaccini et al., 2015), the application of leptin to chronic disease has been severely limited. The gene discussed is LEP; the disease is autoimmune disease.